Consolidated Statement Of Cash Flows

Perseus Proteomics Inc. - Filing #7246138

Concept As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-832,018,000 JPY
-562,409,000 JPY
Income taxes paid
-1,927,000 JPY
-1,927,000 JPY
Net cash provided by (used in) operating activities
-833,898,000 JPY
-564,274,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-142,998,000 JPY
-163,870,000 JPY
Net cash provided by (used in) investing activities
-150,343,000 JPY
-212,989,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-1,000 JPY
-20,000 JPY
Net cash provided by (used in) financing activities
63,943,000 JPY
-20,000 JPY
Effect of exchange rate change on cash and cash equivalents
16,783,000 JPY
7,365,000 JPY
Net increase (decrease) in cash and cash equivalents
-903,514,000 JPY
-769,918,000 JPY
Cash and cash equivalents
1,541,419,000 JPY
2,444,934,000 JPY
3,214,852,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.